Zai Lab Announces Participation in May and June Investor Conferences
16 Mayo 2024 - 6:30AM
Business Wire
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that
members of the Company’s senior management team will participate in
the following investor conferences in May and June 2024:
J.P. Morgan 20th Annual Global China
Summit Panel Discussion: Thursday, May 23, 2024, 10:00 a.m. HKT
Location: Shanghai, China
Jefferies Global Healthcare Conference
Fireside Chat: Wednesday, June 5, 2024, 3:30 p.m. ET in Track 2
Location: New York, New York
Goldman Sachs 45th Annual Global
Healthcare Conference Presentation: Wednesday, June 12, 2024,
1:20 p.m. ET Location: Miami Beach, Florida
About Zai Lab
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative,
research-based, commercial-stage biopharmaceutical company based in
China and the United States. We are focused on discovering,
developing, and commercializing innovative products that address
medical conditions with significant unmet needs in the areas of
oncology, autoimmune disorders, infectious diseases, and
neuroscience. Our goal is to leverage our competencies and
resources to positively impact human health in China and
worldwide.
For additional information about Zai Lab, please visit
www.zailaboratory.com or follow us at
www.twitter.com/ZaiLab_Global.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240516389098/en/
Investor Relations: Christine Chiou / Lina Zhang +1 (917)
886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com /
lina.zhang@zailaboratory.com
Media: Shaun Maccoun / Xiaoyu Chen +1 (415) 317-7255 /
+86 185 0015 5011 shaun.maccoun@zailaboratory.com /
xiaoyu.chen@zailaboratory.com
Zai Lab (NASDAQ:ZLAB)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Zai Lab (NASDAQ:ZLAB)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024